RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Leiomyosarcoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Pelvic transarterial chemoembolisation for recurrent uterine leiomyosarcoma: technical challenges and clinical outcomes
Christabelle Tee, European Society of Radiology (19 October 2026)
https://doi.org/10.26044/ranzcr2026/c-176
- 2.
Orbital Apex Syndrome Associated with Peripheral T-Cell Lymphoma and Uterine Leiomyosarcoma: A Report of Synchronous Primary Tumors.
Ortiz A et al., Archivos de la Sociedad Espanola de Oftalmologia (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42887717/
- 3.
Cutaneous Leiomyosarcoma of the Head and Neck: Appreciation of a More Indolent Biological Behavior and Implications for Its Management.
de Bree Eelco et al., Head & neck (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42885217/
- 4.
Primary Cardiac Leiomyosarcoma in a Young Patient: A Therapeutic Challenge.
Calzadilla-Gutierrez Harold R et al., JACC. Case reports (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42560293/
- 5.
Prognostic factors and treatment outcomes in uterine leiomyosarcoma: a 24-year experience from a single center
方晨燕 et al., BMC Women s Health (8 October 2026)
https://doi.org/10.1186/s12905-026-04950-w
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172 · Recruiting · Phase 1 · Epkin
Ages 18 and over
https://clinicaltrials.gov/study/NCT06789172
- 2.
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677 · Recruiting · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Ages 18 and over
https://clinicaltrials.gov/study/NCT04031677
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Leiomyosarcoma
Leiomyosarcoma is a rare cancer that develops from smooth muscle cells. It can arise in the uterus, the walls of blood vessels, the abdomen or the limbs. Treatment usually involves surgery, sometimes with radiotherapy or chemotherapy. Care is best provided by a specialist sarcoma team, and research into new treatments is ongoing.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Leiomyosarcoma?
Leiomyosarcoma is a rare cancer that develops from smooth muscle cells. It can arise in the uterus, the walls of blood vessels, the abdomen or the limbs. Treatment usually involves surgery, sometimes with radiotherapy or chemotherapy. Care is best provided by a specialist sarcoma team, and research into new treatments is ongoing.
How many clinical trials are available for Leiomyosarcoma?
RareWays currently indexes 140 clinical trials for Leiomyosarcoma, of which 27 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Leiomyosarcoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Leiomyosarcoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.